Good to see this management team has the willing to reset market values, but how? I only found highlighted risk factors... Anyway something good to be expected in the near future. A peer reviewed paper, shouldn't take long for summarizing a P1 trial? IND and the fast track, hopefully they can work more efficiently? Further funding by Life Biosciences? Not favorable but no better choices now.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $128.9M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $188.8K | 13.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 20724621 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 1182673 | 6 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |